title: [Primary or Secondary Prophylaxis of AMD with Anthocyanins?].
abstract: Bilberry extracts containing anthocyanins have become rather popular within the last 2 years among patients with age-related macular degeneration (AMD) in Switzerland as a medication for primary or secondary prophylaxis. So far human study results concerning safety and efficacy in AMD patients are not available. The present state of the scientific literature concerning the use of anthocyanins with relation to AMD will be analysed in this review.
authors.affiliation: Abteilung für Retinologie, Klinik Pallas, Olten, Schweiz. heinrich.gerding@klinikpallas.ch
authors.forename: H
authors.initials: H
authors.lastname: Gerding
mesh_terms: D000872:Anthocyanins / Q000008:administration & dosage*; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy* / Q000517:prevention & control*
chemical_list: D000872:Anthocyanins